Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 8;15(4):1068.
doi: 10.3390/cancers15041068.

Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now?

Affiliations
Review

Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now?

Joyce W Y Chan et al. Cancers (Basel). .

Abstract

The demand for parenchyma-sparing local therapies for lung cancer is rising owing to an increasing incidence of multifocal lung cancers and patients who are unfit for surgery. With the latest evidence of the efficacy of lung cancer screening, more premalignant or early-stage lung cancers are being discovered and the paradigm has shifted from treatment to prevention. Transbronchial therapy is an important armamentarium in the local treatment of lung cancers, with microwave ablation being the most promising based on early to midterm results. Adjuncts to improve transbronchial ablation efficiency and accuracy include mobile C-arm platforms, software to correct for the CT-to-body divergence, metal-containing nanoparticles, and robotic bronchoscopy. Other forms of energy including steam vapor therapy and pulse electric field are under intensive investigation.

Keywords: local treatment; lung cancer; lung cancer screening; robotic bronchoscopy; transbronchial ablation techniques.

PubMed Disclaimer

Conflict of interest statement

All authors completed the ICMJE uniform disclosure form. Calvin S. H. Ng is a consultant for Johnson and Johnson; Medtronic, USA; and Siemens Healthineer. Rainbow W. H. Lau is a consultant for Medtronic, USA; and Siemens Healthineer. All the remaining authors declare no potential conflicts of interest that exist with any companies/organizations whose products or services are discussed in this article.

Figures

Figure 1
Figure 1
(A,B) Right lower lobe lung lesion before (A) and after (B) the first transbronchial microwave ablation in two axes on a cone beam CT scan. The lesion is marked by orange tracings while the green and red ovals represent the predicted ablation zone. In (B), ablative changes represented by ground glass opacities are seen surrounding the ablation catheter as predicted; however, the margin was only 2 mm. Therefore, repositioning of the ablation catheter and re-ablation were performed as shown in (C), and the final cone beam computer tomography (CBCT) shows a satisfactory margin of 6.7 mm.
Figure 2
Figure 2
Images during ENB navigation using the IllumisiteTM platform. (A) Tip of the locatable guide pointing directly at the lesion (represented by the green ball) after peripheral navigation. In (B), the locatable guide was removed, but there were positional sensors embedded in the extended working channel which is shown pointing slightly off-center at the lesion. In (C), the crosshair is shown, pointing slightly off-center at the lesion which would require further manipulation to ensure target view, while the tip of the catheter is shown to be 2 cm from the target lesion.
Figure 3
Figure 3
Picture of the operating room setup during Cios Spin® mobile C-arm image acquisition.
Figure 4
Figure 4
An example of robotic-assisted bronchoscopy by Auris MonarchTM with cone beam CT in a hybrid operating room. This improves the accuracy of navigation, biopsy, or local treatment.
Figure 5
Figure 5
During robotic-assisted bronchoscopy by Auris MonarchTM, multiple panels can be visualized simultaneously: the left-hand panel shows the real-time bronchoscopic view, the middle ones show the bull’s eye view with the centered crosshair and the lesion (in yellow); the right-hand panels show the preoperative CT scan images in three perpendicular axes.

Similar articles

Cited by

References

    1. Ginsberg R.J., Rubinstein L.V. Randomized Trial of Lobectomy Versus Limited Resection for T1 N0 Non-Small Cell Lung Cancer. [(accessed on 8 November 2022)];Ann. Thorac. Surg. 1995 60:615–623. Available online: https://pubmed.ncbi.nlm.nih.gov/7677489/ - PubMed
    1. Aberle D.R., Adams A.M., Berg C.D., Black W.C., Clapp J.D., Fagerstrom R.M., The National Lung Screening Trial Research Team Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. [(accessed on 10 April 2020)];N. Engl. J. Med. 2011 365:395–409. Available online: http://www.nejm.org/doi/10.1056/NEJMoa1102873. - DOI - PMC - PubMed
    1. De Koning H.J., van der Aalst C.M., de Jong P.A., Scholten E.T., Nackaerts K., Heuvelmans M.A., Lammers J.W.J., Weenink C., Yousaf-Khan U., Horeweg N., et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. [(accessed on 10 May 2022)];N. Engl. J. Med. 2020 382:503–513. Available online: https://pubmed.ncbi.nlm.nih.gov/31995683/ - PubMed
    1. Leventakos K., Peikert T., Midthun D.E., Molina J.R., Blackmon S., Nichols F.C., Garces Y.I., Hallemeier C.L., Murphy S.J., Vasmatzis G., et al. Management of Multifocal Lung Cancer: Results of a Survey. [(accessed on 8 November 2022)];J. Thorac. Oncol. 2017 12:1398–1402. Available online: https://pubmed.ncbi.nlm.nih.gov/28583587/ - PMC - PubMed
    1. Warth A., Macher-Goeppinger S., Muley T., Thomas M., Hoffmann H., Schnabel P.A., Penzel R., Schirmacher P., Aulmann S. Clonality of Multifocal Nonsmall Cell Lung Cancer: Implications for Staging and Therapy. [(accessed on 8 November 2022)];Eur. Respir. J. 2012 39:1437–1442. Available online: https://pubmed.ncbi.nlm.nih.gov/22075483/ - PubMed

LinkOut - more resources